Randomized, placebo-controlled study of once-weekly exenatide in 44 non-diabetic, obese children ages 1018, which found a 2.3% decrease in BMI with exenatide compared with placebo
198 WangX.ZhouY.KimH
Most clinical studies evaluating Wegovy for weight loss used the 2.4mg weekly dose, which is why it is considered the target treatment level for many patients
5 Randomized data suggest that intermittent energy restriction achieves similar HbA1c reductions to continuous energy restriction, with no clear between-group differences in GLP-1 concentrations, so any specific GLP-1 benefit of IF remains uncertain
The compounded formulations available through Joi + Blokes (or any compounded pharmacy) are not the same as the FDA-approved finished drug products listed above
Jin J, Fang F, Gao W, Chen H, Wen J, Wen X, et al